DiscoveRx

NEW YORK (GenomeWeb News) – DiscoveRx today said that it has acquired BioSeek, maker of the BioMAP platform of cell-based disease models for drug screening.
Financial terms of the deal were not disclosed.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Compugen and DiscoveRx today announced a collaboration to commercialize specially designed peptides matched with specific G protein-coupled receptor targets.

By Adam Bonislawski
Two papers published in the current edition of Nature Biotechnology add significantly to the publicly available data on the specificity of kinase inhibitors.

Starting in the first quarter of 2011, DiscoveRx plans to add its own panel of cell-based assays to the KinomeScan service as an offering.

The co-marketing agreement will give Jubilant’s drug developer customers cell-based screening services.

BioFocus will offer DiscoveRx's GPCR and cAMP assays as part of its screening services.

DiscoveRx will provide GSK with access to its beta-arresting parental cell lines, clones, and associated reagents.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.